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one liter/day. On day 13, the BUN was 78 mg/dl and the serum
creatinine was 3.5 mg/dl. A blood culture grew methicillin-resistant
Staphylococcus aureus. Recurrent episodes of bradycardia required
placement of a cardiac pacemaker; his blood pressure decreased from
130/80 mm Hg to 100/60 mm Hg. The serum albumin was 1.5 g/dl. The
BUN and serum creatinine began to increase again, although he
remained nonoliguric with a urine output greater than one liter/day.
Urinalysis revealed numerous granular casts and epithelial cells. Urine
osmolality was 370 mOsm/liter. The urine contained no white blood
cells and an insignificant amount of protein. The BUN and serum
creatinine increased to 154 mg/dl and 7.4 mg/dl respectively on the 17th
hospital day, and peritoneal dialysis was initiated. The urine output
decreased to 10 mI/hr. Peritoneal dialysis was continued until the 36th
hospital day. On the 43rd hospital day, the BUN was 28 mgldl and the
serum creatinine was 1.2 mg/dl. The hospital course was complicated
by anoxic encephalopathy, recurrent sepsis, and respiratory failure.
The patient was discharged to his home two months later with a BUN
of 10 mg/dl and a serum creatinine of 1.1 mgldl.
Discussion
Case presentation
A 26-year-old white man suffered a gunshot wound to the right groin.
He lost a large amount of blood and had a cardiopulmonary arrest. After
intubation, CPR was administered, and he was brought to the hospital,
where he was found to have a right common femoral artery and vein
transection. The femoral vein and external iliac artery were ligated, and
a graft was placed to repair the femoral artery. Postoperatively he
continued to lose blood and became hypotensive and oliguric. He
received 10 units of packed red blood cells and 2 units of fresh frozen
plasma. On transfer to the Massachusetts General Hospital, his blood
pressure was 45/20 mm Hg. A second surgical procedure disclosed a
large hematoma and diffuse bleeding as well as a retroperitoneal
hematonia; hydronephrosis was not found, and the bladder and ureteral
system were patent. The blood urea nitrogen (BUN) on admission was
21 mgldl and the serum creatinine was 2.3 mgldl. Although he received
another 21 units of packed red blood cells, 20 units of fresh frozen
plasma, and 10 units of platelets, he remained hypotensive; phenyleph-
rine and norepinephrine maintained his blood pressure at 105/62 mm
Hg. Furosemide and mannitol were administered by continuous infu-
sion. His urine output decreased to 30—40 ml/hr, and examination of the
urine revealed many granular pigmented casts, On the third hospital
day, the BUN and serum creatinine were 44 mg/dl and 4.8 mgldl
respectively; he continued to require pressors for blood pressure
support.
On the 5th hospital day, his urine output increased from 70 to 100
mi/hr. On the 6th hospital day, the BUN and serum creatinine peaked
at 91 mg/dl and 7.2 mg/dl respectively. On the 8th hospital day, the
serum creatinine was 4.9 mg/dl and urine output remained greater than
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DR. JOSEPH V. BONVENTRE (Medical Services, Massachu-
setts General Hospital; Associate Professor of Medicine, Har-
vard Medical School; and Associate Director of The Harvard!
Massachusetts Institute of Technology Division of Health Sci-
ences and Technology, Boston, Massachusetts): This patient
had two episodes of acute renal failure early in his hospitaliza-
tion after a nearly fatal gunshot wound. The first episode,
clearly caused by blood loss, resulted in hypotension and renal
ischemia. Ischemia also contributed to the second episode, but
his medical condition was then complicated by sepsis and a low
serum albumin, which likely predisposed him to acute ischemic
renal failure. In this Forum, I will review the pathophysiologic
mediators that have been implicated in the development of
isehemic acute renal failure. I will limit my discussion to
ischemia and its ramifications and will not discuss sepsis,
nephrotoxins, or other aspects of multisystem disease that
frequently contribute to the development of ischemic acute
renal failure.
The pathophysiology of ischemic acute renal failure is com-
plex. By definition, this form of acute renal failure is initiated by
inadequate blood flow. Inadequate blood flow can be due to
decreased cardiac output, as can occur with acute cardiac
decompensation. It can accompany renal artery stenosis or
occlusion, or it can be due to intrarenal smaller vessel lesions
such as atherosclerosis, atheroemboli, or vasculitis. It has been
known for many years that restoration of total renal blood flow
to normal shortly after an ischemic insult does not prevent the
maintenance phase of acute renal failure. Thus, while reduced
renal blood flow and/or alterations in the distribution of renal
blood flow may contribute to the maintenance phase of acute
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renal failure, ischemia sets off a sequence of epithelial cell
pathophysiologic processes that, once initiated, perpetuates the
tissue damage and functional defects independent of total renal
blood flow.
Abnormal regulation of local blood flow may play an impor-
tant role in ischemic acute renal failure. The functional integrity
of the microvasculature depends on the proper balance between
vasoconstrictive and vasodilatory factors. Damage to the endo-
thelium or alteration in endothelial function can result in local
vasoconstriction due to increased production of vasoconstric-
tive substances such as endothelin and to decreased production
of vasodilatory substances such as nitric oxide. We have found,
for example, that the vasodilatory response to acetylcholine
decreases in aortic rings exposed to low oxygen tension [1].
Alterations in endothelial cell function can be important in the
local loss of autoregulation that occurs in ischemic renal failure
[2].
There is evidence that heterogeneity of blood flow plays an
important role in the pathophysiology of ischemic renal failure.
The early pathologic descriptions of "lower nephron nephro-
sis" by Oliver emphasized the patchy nature of the tubular
injury and the localization of damage to the distal part of the
nephron [3]. This could be due to differential susceptibility of
nephron segments to ischemia and/or to differential levels of
ischemia due to heterogeneity of blood flow. A pale cortex and
"hyperemic" medulla generally have been considered features
of acute ischemic renal failure [4]. Some investigators have
interpreted these findings as evidence for redistribution of blood
flow from cortex to medulla; others believe these features point
to increased congestion in the medulla. Vascular congestion in
the outer medulla [5] and decreased blood flow to this region [6]
occur in experimental ischemic acute renal failure in rats.
Hellberg et al measured the distribution of blood flow in the rat
kidney after 60 minutes of ischemia using single-fiber laser
Doppler probes placed in superficial cortex, outer medulla, and
inner medulla [7]. After ischemia, blood flow decreased to 60%
of pre-ischemic levels in superficial cortex and to 16% of
pre-ischemic levels in outer medulla, but increased to 125% of
control values in inner medulla. This decrease in blood flow to
the outer medulla diminishes the oxygen and nutrient delivery
to the tubules in this region, thus increasing the risk of cell
injury. Swelling of endothelial or tubular epithelial cells, espe-
cially in the outer medulla, may be responsible for interference
with flow through the vasa recta and for compromise of the
blood flow. Thus, maneuvers that maintain endothelial cell
integrity, dilate the vasculature, or prevent tubular cell swelling
may be advantageous in preserving renal function.
The vulnerability of the tubules in the outer medulla is also
increased by the vasa recta countercurrent exchange of oxygen
that results in a marked drop-off in oxygen tension with
increasing distance into the medulla from the cortex [8]. Many
medullary cells increase their rates of glycolysis in an anaerobic
environment, but the thick ascending limb cells in the outer
medulla cannot preserve their ATP levels despite enhanced
glycolysis [9]. Epstein, Brezis, and Rosen, using the isolated
perfused kidney preparation, have emphasized the vulnerability
of the thick ascending limb as reflected by structural damage to
this nephron segment. They attribute this vulnerability to the
mismatch between the vigorous metabolic demand of, and the
inadequate oxygen delivery to, the thick ascending limb [10—
12].
Tubular cell damage
Generalized and/or localized ischemia to renal tissue dam-
ages the tubular cells themselves. Injured tubular cells release
"cellular debris" into the tubular lumen, and this process
contributes to cast formation [13], tubular lumen obstruction,
increased tubular pressures [14, 15], and a marked reduction in
single-nephron glomerular filtration rate. The damaged cells
slough, leaving a denuded basement membrane; increased
tubular fluid then leaks back into the peritubular capillaries. The
resulting effective reduction in GFR is likely much more impor-
tant than are glomerular endothelial and epithelial cell changes
and the subsequent effects on the glomerular capillary ultrafil-
tration coefficient [16, 17]. Furthermore, the tubular cell swell-
ing in the confined space of the outer medulla mechanically
adds to capillary obstruction and causes medullary congestion,
decreased medullary blood flow, and further ischemia and
tubular cell injury. These changes establish a positive-feedback
process that exacerbates the injury. The damage to the tubular
cell represents the final event that accounts for much of the
pathophysiology of ischemic acute renal failure.
In this discussion I will review the many factors that are
believed to contribute to tubular cell injury and death in
ischemic acute renal failure. Many episodes of human acute
ischemic renal failure are multifactorial; affected patients are
frequently septic, are receiving nephrotoxic drugs such as
aminoglycosides, have multiple organ system failure, and have
suboptimal nutritional status [181. I will, however, limit my
discussion to ischemia alone, as the renal effects of other
factors contributing to acute ischemic renal failure easily could
be topics for many Nephrology Forums. Furthermore, since
this series recently contained a review by Toback of the factors
potentially operative in repair after acute renal failure [19], I
will not deal with that aspect of acute ischemic renal failure,
although I believe that understanding the repair process is just
as important as understanding the features of the injury and cell
death itself. Time and space will limit my discussion to an
overview of the controversies that mark this field. Some of the
disagreements regarding interpretation of data relate to the use
of multiple experimental "in-vivo" models and the inability to
exactly mimic human acute renal failure in an experimental
model. Because of the difficulty in studying cellular function
and biochemistry in vivo, many of the studies have been
performed on isolated tubules in vitro under conditions de-
signed to mimic those in vivo, but clearly these are not able to
reproduce all the features of ischemia, which include: hypoxia,
substrate depletion, metabolic product accumulation, decreases
in pH, and extracellular electrolyte abnormalities.
The mechanisms responsible for the tubular epithelial cell
injury and death that occur as a result of ischemia are contro-
versial [20, 211. It is clear that many cellular systems change
markedly with ischemia. No general agreement exists, how-
ever, as to which of these metabolic changes cause cell death
and which are secondary to the cellular injury. Nevertheless we
should consider each of these proposed pathophysiologic mech-
anisms because our attempts at protecting the cells ultimately
will depend on an understanding of which factors are primary.
First I will briefly discuss the morphologic correlates of cell
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injury that occur during the early stages of acute renal failure
prior to cell regeneration and repair. I then will discuss various
pathophysiologic mechanisms of cell injury including the roles
of adenine nucleotides, reactive oxygen species, acidosis, cal-
cium, phospholipases, amino acids, and proteases. Finally I will
evaluate a potential role for apoptosis in the pathophysiology of
the tissue injury.
Morphologic correlates of ischemic tubular cell injury. Mor-
phologic changes that occur with ischemic acute renal failure
provide some insight into its pathophysiology, although fre-
quently there is not a good correlation between structural and
functional changes in human acute ischemic renal failure. The
earliest morphologic changes that occur with ischemia include
loss of the apical brush border and blebbing of apical mem-
branes. Molitoris and colleagues found that after 10 minutes of
ischemia, sodium-potassium ATPase activity, normally present
only on the basolateral aspects of proximal tubular cells, is
found on the apical membrane also [22—25]. In addition, apical
membrane lipid composition changes markedly after periods of
ischemia as short as 5 minutes. These changes, together with
the loss of basolateral interdigitations [26], likely account for
the functional decrease in sodium and sodium-coupled proximal
transport properties. Changes in the actin cytoskeleton might
be responsible for the loss of polarity of the proximal tubule cell
[27].
With more advanced ischemic injury, vacuoles form within
the cell, mitochondria swell, "flocculent mitochondrial densi-
ties" appear, and nuclei undergo pyknosis. Cells detach from
the basement membrane, leaving gaps, and the remaining cells
"flatten-out" along the basement membrane, Cellular debris
and intratubular protein form casts and obstruct the tubules,
causing increased pressures proximal to the obstruction; the
fluid that leaks out from the obstructed tubules causes tissue
edema. Later I will discuss the possibility that another form of
injury, so-called "apoptosis," contributes to cell death in
ischemic acute renal failure.
Cell swelling represents an important response to ischemia.
Cell volume is controlled by the sodium-potassium ATPase
pump, which produces a negative intracellular charge and a low
intracellular sodium concentration [28, 29]. With oxygen de-
privation and ATP depletion, the sodium-potassium ATPase
pump becomes inactive; the cells thus become depolarized, and
intracellular sodium and chloride accumulate. Using electron
microprobe techniques, Mason and colleagues measured total
cellular sodium and chloride in proximal and distal tubules after
ischemia in rats [30]. Sodium and chloride content increased
both in proximal and distal cells, with the greater changes in
proximal cells. As a result, the cells take up water and swell.
An intact cytoskeleton appears to help maintain normal
proximal cell volume 1311. Disruption of the cytoskeleton as a
consequence of ischemia can contribute to cell swelling. The
addition of impermeant solutes to renal preservation solutions
in kidneys destined for transplantation prevents this cell swell-
ing and helps preserve kidney viability [32].
Cell swelling contributes to obstruction of the tubular lumen
and compromises blood supply to regions of the kidney precar-
iously dependent on delicate vasa recta to provide oxygen
delivery. Although a reduction in cell swelling does not prevent
ischemic cell death in an isolated cell preparation, in the organ,
prevention of cell swelling does prevent tubular and venous
obstruction and allows more oxygen delivery to the partially
ischemic or post-ischemic tissue. Agents such as mannitol that
inhibit cell swelling partially protect the kidney against the
functional deficits induced by ischemia and also decrease outer
medullary congestion [5, 33].
Adenine nucleotide metabolism. When a cell or tissue that
functions primarily on aerobic metabolism becomes ischemic,
cellular ATP levels, the energy currency of the cell, fall rapidly.
In the kidney, complete ischemia for 10 minutes reduces ATP
levels 70% to 90% [341. Cortical levels drop much more
dramatically than do medullary levels [35, 36], likely because of
the glycolytic metabolism of some medullary cells, which are
adapted to an environment that is relatively anoxic even under
normal conditions. In the outer and inner medullary collecting
ducts, glycolytic metabolism alone can maintain ATP levels at
60% to 70% of normal [9, 37, 38] and glycolysis alone can
sustain acid secretion in the outer medullary collecting duct
[38], the latter being a dominant function of this nephron
segment. Cells in these nephron segments also can increase
their glycolytic rate more efficiently when oxidative metabolism
is blocked than can the proximal tubule cells [39]. Increased
medullary glycolysis does not mean, however, that all medul-
lary cells are insensitive to an ischemic insult. Given the
marked heterogeneity of cellular structure within this region, an
aggregate measurement of glycolytic rates or ATP levels in the
medulla does not always reflect levels within some specific
cells. The medullary thick ascending limb, for example, cannot
sustain normal ATP levels in the presence of inhibition of
oxidative metabolism despite its increased glycolytic rate [9].
A plethora of cellular processes critically depend on hydro-
lysis of the high energy phosphate of ATP. These processes,
which include protein synthesis, lipogenesis, and membrane
transport, cease or become significantly impaired when cellular
ATP is markedly depleted. Ion gradients dissipate without the
ATP necessary for the function of the corresponding ion
transporter ATPases. Sodium and calcium accumulate in the
cell. Deacylation-reacylation cycling is disrupted, and fatty
acids accumulate because not enough energy is available for
reacylation. Acidosis develops as the cell derives more energy
from glycolytic metabolism.
With ischemia, ATP is degraded to ADP and AMP. The AMP
is then acted upon by 5'-nucleotidase (or is first converted to
IMP by adenylate deaminase prior to the action of 5'-nucleoti-
dase) with the resultant formation of adenosine, inosine, and
hypoxanthine. The nucleotides (ATP, ADP, AMP, IMP) are
relatively impermeable to cells; in contrast, the nucleosides
(adenosine and inosine) and the base (hypoxanthine) can leak
out of cells and decrease the purine substrate pool. Further-
more, the hypoxanthine can be converted by xanthine oxidase
to uric acid. In the process, reactive oxygen species are formed,
and these can contribute to the ischemic damage.
Not all the cellular injury that occurs with ischemia happens
during the ischemic period. A significant fraction of the injury
occurs after reperfusion. During reoxygenation, the efficiency
of ATP reaccumulation is critically important for cell survival.
During reperfusion and reoxygenation, the possible pathways
for resynthesis of ATP are de-novo purine synthesis from
nonpurine precursors, and "salvage pathways" from AMP,
adenosine, adenine, or other purine bases, nucleosides, or
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nucleotides. De-novo synthesis probably plays little role in the
recovery of ATP levels after ischemia.
The importance of depletion of the adenine nucleotide pool
has been evaluated in experiments designed to enhance this
pool in an attempt to protect the kidney against ischemic injury.
Siegel and colleagues, in a large series of experiments, demon-
strated that intravenous infusion of ATP and magnesium chlo-
ride protected rat kidneys against 30 minutes of ischemia, even
when the agents were administered after the ischemic insult [40,
411. This protection correlated with an increased rate of recov-
ery of ATP levels [42]. Exogenous AMP was as effective as
ATP in enhancing the recovery rate of tissue ATP levels upon
reperfusion; this finding led to the conclusion that the adminis-
tration of adenine nucleotides enhances the nucleotide precur-
sor pool available for the resynthesis of ATP. Further evidence
for the importance of maintenance of the purine pool for
restoration of ATP levels derives from experiments performed
with the ADP analogue, adenosine a,f3-methylene diphosphate,
which inhibits 5'-nucleotidase [43]. Pretreatment with this agent
increased the residual nucleotide pool after 45 minutes of
ischemia and protected kidneys against ischemic injury as
determined by inulin clearance 24 hours after the insult.
Reactive oxygen species. Reactive oxygen species (ROS)
have been implicated in the renal cell injury that occurs with
reperfusion after ischemia. Three lines of evidence have been
presented to suggest that ROS are involved. (1) Products of
lipid peroxidation are generated on reperfusion, and these are
presumed to derive from ROS action on membrane lipids [44,
45]. (2) Scavengers such as superoxide dismutase (SOD), glu-
tathione, and vitamin E, as well as inhibitors of ROS produc-
tion, such as the iron chelator deferoxamine, have been re-
ported to protect against ischemic injury [46, 47]. (3) Exposure
of kidney subcellular organelles or microsomes to ROS-gener-
ating systems mimics some features of ischemic injury [45, 48].
In mammals, the chemical reduction of oxygen can occur via
the mitochondrial tetravalent reduction process or can result
from a series of sequential univalent reductions (Fig. 1). The
first univalent reduction yields superoxide (Op); two superox-
ide radicals then react to generate hydrogen peroxide and
Fig. 1. Reactions involved in metabolism of
molecular oxygen.
molecular oxygen in a reaction markedly potentiated by super-
oxide dismutase. Hydrogen peroxide can (1) be converted to
molecular oxygen and water by catalase; (2) oxidize glutathione
(GSH) to GSSH, a reaction catalyzed by GSH peroxidase; (3)
participate with superoxide and Fe2/Fe3 in a two-step
"Haber-Weiss" reaction that generates the hydroxyl radical;
(4) react with iron to generate highly reactive ferryl or perferryl
Fe-0 complexes; or (5) react with halides in the presence of the
neutrophil enzyme myeloperoxidase to generate hypohalous
acids that also are very reactive.
Reactive oxygen species may derive from a variety of sources
in post-ischemic tissue. When mitochondria are deprived of
oxygen, the electron transport chain intermediates become
more reduced and, when oxygen delivery to the tissue is
restored, free electrons can increase superoxide generation. A
second important source of ROS is xanthine oxidase. In isch-
emic tissue, xanthine oxidase levels increase due to conversion
from xanthine dehydrogenase. Under normoxic conditions,
xanthine dehydrogenase catalyzes the transfer of electrons to
nicotine adenine dinucleotide (NAD) and oxidizes xanthine and
hypoxanthine to uric acid. With ischemia and reperfusion,
however, xanthine dehydrogenase is converted to xanthine
oxidase by a Ca2-dependent protease [49]. Xanthine oxidase
uses molecular oxygen as an electron acceptor and generates
superoxide during the oxidation of hypoxanthine, which in-
creases in concentration in the post-ischemic tissue. In one
study, tissue hypoxanthine levels increased approximately 300-
fold after 60 minutes of renal ischemia [50]. This source of ROS
is likely more relevant in rats than in humans; the human kidney
has low levels of xanthine oxidase [51].
Prostaglandin H (PGH) synthase and lipoxygenase, the en-
zymes involved in the metabolism of arachidonic acid, com-
prise a third source of ROS. Both of these enzymes produce
superoxide in the presence of NADH or NADPH [52]. The
neutrophils present in the post-ischemic tissue are a fourth
source of ROS. These neutrophils can directly participate in the
damage to the epithelial or endothelial cell, or they can act via
the production of cytokines, such as leukotrienes, which can
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further compromise the local blood supply by causing vasocon-
striction [53, 54]. Activated neutrophils produce superoxide as
a result of activity of the NADPH oxidase enzyme [551.A fifth
source, the auto-oxidation of catecholamines, generates super-
oxide and hydrogen peroxide [56, 57]. Finally, the oxidative
enzymes of the endoplasmic reticulum, such as those of the
P450 mixed-function oxidase system, and the peroxisomes
represent other potential sources of ROS.
Reactive oxygen species can damage tissue in a variety of
ways. They can cause lipid peroxidation by abstracting a
hydrogen atom from a polyunsaturated fatty acid of membrane
phospholipids; a conjugated diene forms after molecular rear-
rangement of the fatty acid. The diene then reacts with oxygen
to form a peroxide radical, which can remove hydrogen atoms
from other lipids, generating a chain reaction. Lipid peroxida-
tion can increase plasma and subcellular membranes' perme-
ability [58], impair enzymatic processes and ion pumps [45],
and damage DNA [59, 60]. In addition, direct oxidation of
membrane proteins occurs [61], affecting critical proteins such
as the sodium-potassium ATPase and the Ca2 ATPase.
The role of ROS in ischemic renal injury remains controver-
sial because investigators do not all agree that antioxidants
confer protection [62, 63], nor do all agree on the presence of
increased lipid peroxidation or ROS generation in ischemia [62,
63]. Some researchers have reported that exogenously admin-
istered superoxide dismutase protects the kidney [44]. Allopuri-
nol, which inhibits xanthine oxidase, also has been found
protective by some investigators [64] and ineffectual by others
[63, 65]. Glutathione, normally present in high amounts in
tubular cells, can react with and neutralize ROS. Cellular
glutathione levels fall with ischemia [66], and reduced cellular
glutathione levels sensitize cells to oxidative stress [67]. Pro-
tective effects of glutathione have been reported, although it
remains controversial as to whether these effects are due to the
antioxidant characteristics of this compound or due to the
generation of glycine, its metabolic product, independent of
ROS scavenging. As with other ROS scavengers, glutathione
administration has yielded inconsistent results [68, 69].
Acidosis. Ischemia stimulates glycolysis, increasing the gen-
eration of protons, and leading to a reduction in renal pH [70].
The reduced pH inhibits glycolysis by inhibiting phosphofruc-
tokinase, the rate-limiting step in glycolysis. Although severe
acidosis can damage the kidney, we have demonstrated in
hepatocytes and renal tubular cells that mild intracellular aci-
dosis (extracellular pH 6.9) protects cells against anoxia and
substrate deprivation in vitro [71, 721. Weinberg also found that
acidosis protects renal tubular cells [73]. This protection is
associated with the prevention of any increase in total cellular
Ca2 [72]. The mechanism of protection is not clear but might
relate in part to decreased phospholipase activity, given that
some renal phospholipase A2 enzymes have alkaline pH optima
[74, 751. Acidosis stabilizes cell membranes [76]. When blood
flow and oxygen delivery are re-established, the extracellular
pH rapidly returns to normal. It is possible that the increase in
intracellular pH on reperfusion enhances phospholipase A2
activity. Increased activity of phospholipase A2 might lead to
further alteration in membrane structure and secondarily to
increased Ca2 permeability, which in turn would further
stimulate phospholipase A2 activation and perpetuate a posi-
tive-feedback process.
Calcium. Damaged tissues are known to accumulate calcium,
and dead cells are Ca2-laden. As increased levels of cellular
Ca2 can be implicated in a number of processes that are
detrimental to the cell, some investigators have proposed that
Ca2 is a principal mediator of cellular injury associated with
ischemia [77]. Everyone agrees that damaged cells and tissues
accumulate Ca2, but considerable controversy exists as to
whether the increased levels of Ca2 cause ischemic cell and
tissue injury or are a consequence of the injury caused by other
factors.
A large Ca2 concentration gradient is maintained between
the cytosolic compartment and the extracellular milieu of
normal eukaryotic cells. A 10,000-fold concentration gradient (I
mM extracellular to 100 nM intracellular free calcium concen-
tration) is maintained by energy-dependent calcium extrusion
mechanisms and low permeability of the plasma membrane to
Ca2t With ATP depletion due to ischemia, Ca2 extrusion
from the cell via Ca2 ATPases is inhibited [78]. Furthermore,
as ATP levels fall, the activity of the sodium-potassium ATPase
pump on the plasma membrane decreases and raises the intra-
cellular sodium concentration. The resultant decrease in the
trans-membrane sodium concentration gradient potentiates
Ca2 entry into the cell via the sodium-calcium exchanger [79,
80]. Calcium that accumulates in cells can be taken up into
non-mitochondrial as well as mitochondrial compartments.
Under normal conditions, the non-mitochondrial storage sites
play a much more important role in the buffering of calcium
than do the mitochondna [81]. If large amounts of Ca2 enter
the cells, however, the mitochondria become more important
storage sites, representing a very-high-capacity system for
buffering Ca2. Very large amounts of Ca2 can be taken up
into mitochondria in the presence of ATP. Small amounts of
mitochondrial uptake of Ca2 produce little functional damage
to these organelles. Larger amounts of Ca2 uptake, however,
cause mitochondrial swelling [82], uncoupling of oxidative
phosphorylation [83], and the release of free fatty acids, which
themselves uncouple oxidative phosphorylation [841.
Ionized calcium can be detrimental to cells in a number of
additional ways. An increase in intracellular Ca2 stimulates
plasma and endoplasmic/sarcoplasmic reticulum Ca2 -
ATPases. The increased activity of these ATPases increases
energy consumption and further contributes to ATP depletion.
An increase in cytosolic free Ca2 concentration activates
Ca2-dependent proteases and phospholipases; these enzymes
lead to proteolysis and membrane disruption. Elevated Ca2
levels also can disrupt the cell cytoskeleton [85].
If Ca2 participates in the cell injury that characterizes
ischemia, it is reasonable (albeit not essential) to predict that
cellular Ca2 rises prior to the initiation of irreversible cell
damage. Using isolated cardiac myocytes exposed to 30 min-
utes of anoxia and substrate deprivation, we found that cyto-
solic free Ca2 and total cellular and mitochondrial Ca2
content did not increase despite evidence for irreversible con-
tracture and mitochondrial dysfunction [81, 86, 87]. Other
investigators have measured increases in intracellular Ca2 in
anoxic renal tubules or renal cells in culture exposed to meta-
bolic inhibitors (chemical anoxia). Snowdowne and colleagues
found small (less then threefold) increases in cytosolic free
Ca2 in anoxic isolated cardiac cells [88] and cultured kidney
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cells [891. When they reduced extracellular sodium concentra-
tion, the same investigators found much larger increases in
cytosolic free Ca2 concentration (12-fold), which were not
associated with an alteration in cell viability. Mandel and
colleagues evaluated renal tubular mitochondrial Ca2 loading
in anoxia and hypoxia [90] and found that Ca2 accumulates in
the mitochondria during severe hypoxia but not during anoxia.
The Ca2 accumulation with hypoxia, however, is readily
reversible on reoxygenation and appears to be unrelated to the
respiratory dysfunction elicited by short-term hypoxia or an-
oxia. Cytosolic free Ca2 was unchanged after 40 minutes of
anoxia, at a time when respiration was impaired and the plasma
membrane was damaged [91]. Using electron microprobe anal-
ysis techniques, they found no anoxia-induced changes in Ca2
in any cellular compartments. Consistent with the findings in
cardiac myocytes and renal tubules, Lemasters et al found a
loss of cellular membrane integrity as well as mitochondrial
dysfunction in the absence of a significant change in cytosolic
free Ca2 concentration in hepatocytes [92]. Thus, even those
investigators who have found an increase in cytosolic free Ca2
with anoxia have reported changes in Ca2 concentration that
are much smaller than those acute changes observed with
physiologic processes such as cell fertilization or contraction
(10-fold to 25-fold) [93, 94], hormonal stimulation (8-fold) [95],
or extracellular sodium depletion (12-fold) [80].
Others have argued for a primary role of Ca2 in renal tubular
cell injury based on data obtained in experiments in which Ca2
was removed from the bathing medium or cells were exposed to
calcium-channel blockers. If Ca2 is a primary mediator of
tissue damage associated with ischemia, then maneuvers de-
signed to prevent Ca2 entry into the cell would be expected to
prevent anoxic and ischemic cell injury. Wilson and Schrier,
using vital dye exclusion as a measure of viability, found that
the viability of proximal tubular cells in primary culture that
were exposed to anoxia was greater at 48 hours if Ca2 had
been removed from the media for the initial 2 hours post anoxia
[96]. Takano and coworkers found that exposure of isolated
renal tubules to 30 minutes of anoxia in the presence of a
1ow-Ca2 medium (2 pM) reduced LDH release during the
anoxic period but increased LDH release during reoxygenation
[97]. By contrast, Smith and colleagues found that hepatocytes
were more susceptible to toxic injury in the absence of Ca2
than in its presence [98]. In our own studies with isolated adult
rat ventricular cells exposed to anoxia, we found greater
changes in electrolyte composition and decreased ability to
incorporate '4C-phenylalanine into cell protein if the anoxic
incubation was carried out in a bath with Ca2 less than 10 sM
[86].
Calcium-channel blockers have been used extensively to
explore the role of Ca2 in ischemic cell injury. Many studies in
a variety of organ systems have demonstrated a protective
effect of this pharmacologic class of agents [99—101]. These
experiments are of obvious interest because of the widespread
availability and clinical use of these agents. In fact, one can
demonstrate that the protection afforded by these agents is
accompanied by less calcium loading of mitochondria, preser-
vation of mitochondrial function [102], and less overall accu-
mulation of calcium intracellularly.
Controversy has arisen as to the mechanisms of protection of
calcium-channel-blocking agents. Some investigators have in-
terpreted protective effects as due to prevention of calcium
overload of cells with a resultant preservation of viability [100].
In a model of fixed ischemia in vivo and in the isolated rat
kidney, under conditions in which verapamil could not alter
renal blood flow, we found that this agent did not protect the
kidney [33]. Verapamil did protect against ischemic injury in a
norepinephrine model of acute renal failure [33] and we con-
cluded that the protection afforded by verapamil was due to an
inhibition of norepinephrine-induced renal vasoconstriction.
Consistent with the conclusion that verapamil does not directly
protect the renal epithelial cell are the observations by Wein-
berg and colleagues that marginal effects are seen in the isolated
tubule preparation, even at very high doses of verapamil [103].
We found that neither verapamil nor nifedipine protected
isolated non-contracting heart cells [104] or renal tubules (un-
published data) against injury associated with 30 to 40 minutes
of anoxia. On the other hand, when cardiac myocytes were
paced to rhythmically contract in an anoxic environment,
verapamil and nifedipine conferred protection by decreasing the
cellular contractile activity [104]. Calcium-channel blockers—in
particular, diltiazem and verapamil—have been used in an
attempt to decrease the incidence of acute renal failure in the
renal allograft. These agents have been administered to both
donor and recipient, and the incidence of acute renal failure
accounting for delayed graft function has decreased [101]. The
drugs were given to patients who also were receiving cyclospo-
rine, and it is not clear whether the effect on graft function was
related to an independent effect of the calcium-channel blocker,
that is, its ability to block cyclosporine toxicity [105, 106].
Vasoconstriction likely plays an important role in both allograft
acute tubular necrosis and cyclosporine toxicity, so one might
expect that an agent that vasodilates the renal vascular beds
might protect against acute renal failure.
An additional complicating feature in the use of calcium-
channel-blocking agents to test the role of Ca2 in ischemic
injury is that these agents have effects other than their well-
known effects on the slow Ca2 channel. These compounds
antagonize calmodulin and phosphodiesterases [107, 108], and
they probably also have nonspecific "local anesthetic" or
"membrane-stabilizing" actions brought about by their inter-
action with hydrophobic regions of the membrane bilayer [109].
In summary, it remains unclear how important an increase in
cytosolic free Ca2 is to the irreversible renal cell injury that
results from ischemia and reperfusion. Clearly, increases in
smooth muscle Ca2 concentration lead to vasoconstriction,
which can compromise local blood flow. In my opinion, how-
ever, increases in cytosolic Ca2 concentrations are neither
necessary nor sufficient to explain irreversible tubular cell
injury. This is not to say that Ca2 is unimportant. Under
certain circumstances, increases in cytosolic Ca2 concentra-
tion potentiate the cellular insult. For example, it is possible
that mitochondrial loading with amounts of Ca2 that are not of
themselves detrimental will potentiate the toxicity associated
with ROS, as we have reported [48]. One also should consider
that enzymes that participate in the cellular injury associated
with ischemia can be modified so as to be more sensitive to
Ca2. Under these circumstances, Ca2 might play an impor-
tant role without there being any significant increase in its
concentration. For example, the Ca2 sensitivity of phospho-
lipase A2 is increased under in-vitro conditions that mimic brain
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isehemia [1101. If this is the case, a covalent modification of the
enzyme may result in "Ca2-dependent" activation without an
increase in cytosolic free calcium concentration. It would
follow that perhaps the more effective pharmacologic interven-
tion would be directed toward the inhibition of processes that
produce this stable modification of the enzyme rather than
directed toward modifying Ca2 handling by the cell.
Phospholipases. Phospholipase A2s (PLA2) comprise a fam-
ily of enzymes that hydrolyze the acyl bond at the sn-2 position
of phospholipids to generate free fatty acids and lysophospho-
lipids. I have recently reviewed the various forms of PLA2
enzymes and the roles that they play in signal transduction and
other cellular processes [75]; PLA2 likely plays an important
role in ischemic cellular injury [20, 21]. Phospholipid degrada-
tion contributes to ischemic tissue injury in the kidney [111],
brain [112], heart [113], intestine [114], and liver [115]. Phos-
pholipase A2s can contribute to cell injury in many ways: (1)
The PLA2-induced changes in phospholipid integrity and the
toxic actions of free fatty acids and lysophospholipids alter
plasma membrane and mitochondrial membrane permeability
properties and bioenergetic capacities. (2) The lipid peroxida-
tion that occurs with ischemia and reperfusion causes an
increase in susceptibility of cellular membranes to PLA2 [1161.
(3) As one of the PLA2 products, arachidonic acid, is converted
to eicosanoids by the PGH synthase and lipoxygenase en-
zymes, reactive oxygen species are generated. (4) The ei-
cosanoid products of arachidonic acid metabolism are vasoac-
tive and chemotactic for neutrophils, which in turn, may
contribute to the tissue injury [53]. (5) In addition, when the
lipid 1 -O-alkyl-2-acyl-phosphorylcholine is the substrate for
PLA2, the product becomes the precursor for platelet activating
factor, which can activate platelets and cause capillary occlu-
sion.
The extent of the contribution of PLA2 to cell injury associ-
ated with ischemia is controversial [21, 117]. Until recently,
much of the evidence supporting a role for PLA2 was indirect
and was based on measured increases in free fatty acids in
post-ischemic tissues or on the protection afforded by poorly
selective PLA2 inhibitors. The role of Ca2 in activating PLA2
was also unclear; many forms of PLA2 require very high Ca2
concentrations for activation, and the Ca2 concentration sen-
sitivity of intracellular forms of PLA2 was not well character-
ized. Venkatachalam et al reported that unesterified fatty acids
accumulate to very high levels when ATP levels drop below a
critical threshold in renal epithelial cells in culture [118]. The
levels to which free fatty acids accumulated correlated posi-
tively with the extent of cell injury. A non-specific PLA2
inhibitor, quinacrine, protects against phospholipid degrada-
tion, results in a reduction in infarct size after coronary artery
occlusion in rats [113], and also partially preserves the mucosal
permeability barrier in ischemic and reperfused intestine [101].
A 4-thiazolidinone compound (LY178002) inhibits multiple en-
zymes in the arachidonic acid metabolic cascade, including
PGH synthase, 5-lipoxygenase, and PLA2 as well as lipid
peroxidation, and protects the rat brain exposed to transient
global forebrain ischemia [119].
The mitochondria are particularly important sites of PLA2
action, and PLA, activation might have important implications
for cellular energy metabolism [48, 1201. Changes in mitochon-
drial membrane integrity would be expected to impair ATP
generation and hence reduce the energy currency available for
recovery processes [121]. We found that PLA2 activation was
responsible for electron transport chain damage localized to
NADH coenzyme Q reductase, decreased F1-ATPase function,
decreased ADP translocase activity, and increased mitochon-
drial membrane permeability to hydrogen ions, when mitochon-
dna were exposed to Ca2 and reactive oxygen species [48].
Mitochondria, enriched with polyunsaturated fatty acids, were
more susceptible to injury from exposure to Ca2 and ROS; this
susceptibility correlated positively with enhanced PLA2 activ-
ity [122].
Data from other laboratories also support the view that PLA2
plays an important role in mitochondrial injury. The addition of
exogenous PLA2 to hypoxic proximal tubules results in severe
cellular injury and significant decreases in uncoupled respira-
tory rates of the tubules [123]. An understanding of the role of
PLA2 in ischemic injury requires that we (1) characterize PLA2
activity in the organ of interest with regard to apparent molec-
ular size and substrate specificity; (2) determine whether PLA2
enzymatic activity itself is modulated by ischemia and reper-
fusion; and (3) evaluate how potential modulating factors,
including calcium, pH, protein kinase C, and ROS affect PLA2
activity. I will address each of these issues by focusing on our
own experiments using rat kidney, gerbil brain, isolated rat
kidney mitochondna, and isolated rat cortical neurons in cul-
ture.
Recently we characterized PLA2 activity in cytosolic, mito-
chondrial, and microsomal fractions of rat kidneys [741. At least
two forms of PLA2 activity were present in the cytosolic
fraction. A high-molecular-weight form, active against phos-
phatidylcholine (PC) and phosphatidylethanolamine (PE), was
purified and found to have a molecular mass of approximately
110 kD [124]. A smaller form with a molecular mass of approx-
imately 14 kD that is active against PB also was found in the
cytosolic fraction. In the mitochondrial and microsomal frac-
tions, a single dominant form (Mr 14 kD) was active against
both PC and PE. As in the kidney, two forms of PLA2 were
present in the cytosolic fraction of gerbil brain: a high-molecu-
lar-weight form, active against PC and PE, and a smaller form
with a molecular mass of approximately 14 kD, active against
PE. In the mitochondrial and microsomal fractions, again a
single dominant form (Mr 14 kD) was active against both PC
and PE [125].
We measured the PLA2 activity of cytosolic, mitochondrial,
and microsomal extracts of rat kidney [74] and gerbil brain [125]
after ischemia and reperfusion and compared these results with
those from control tissue extracts. Each of the extracts was
assayed under identical free Ca2 concentrations and at pH 7.5.
In kidneys exposed to 45 minutes of clamp-induced ischemia
with one hour of reperfusion, we noted increased cytosolic,
mitochondrial, and microsomal activity. We determined PLA2
enzymatic activity in gerbil brain after 10 minutes of common
carotid occlusion followed by 10 minutes of reperfusion. The
PLA2 specific and total activities increased significantly in each
extract when PC or PE was used as a substrate. In the brain, the
cytosolic PLA2 activity after ischemia and reperfusion in-
creased when PC, PE, phosphatidylinositol (P1), or l-hexade-
cyl-2-arachidonyl-PC was used as a substrate. The highest
PLA2 specific activity was found in the presence of 1-hexade-
cyl-2-arachidonyl-PC. Ischemia and reperfusion did not change
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the gel filtration elution patterns of PLAI activity of the various
forms of the enzyme in either kidney or brain.
In both rat kidney and gerbil brain, cytosolic PLA2 activity
increased when we raised the Ca2 concentration from 100 nM
(baseline cytosolic Ca2 concentration in renal epithelial cells
and neurons) to 200—300 nM, values well within the range
reached in response to physiologic and pathophysiologic stimuli
[95, 126]. Mitochondrial PLA2 activity also was Ca2 concen-
tration-dependent, but activity was not increased until [Ca2]
was increased to levels greater than 1 jsM. Activity increased,
however, as [Ca2] increased from 1 to 5 jsM, values within the
range of variation of mitochondrial matrix [Ca2] under physi-
ologic and pathophysiologic states [90, 127].
In both kidney and brain, cytosolic, mitochondrial, and
microsomal PLA, activities were optimal at pH 8.5. Ischemia
and reperfusion did not alter the pH optima of cytosolic or
mitochondrial PLA2 activity. This alkaline pH optimum may
explain the acidosis-associated protection against anoxic injury
that we reported [61] and have discussed previously.
Thus, rat kidney and gerbil brain have various forms of
Ca2tdependent PLA2 activity. Ischemia and reperfusion result
in stable activation of both soluble and membrane-associated
forms. This stable activation of PLA2 may play an important
role in cellular injury associated with ischemia and reperfusion
and may account for continued phospholipid degradation after
the acute insult is reversed.
Additional forms of PLA2 might be present in the kidney. In
a preliminary report, Morrison and Irwin noted the presence of
a Ca2-dependent, PE-specific, cytosolic PLA2 in the rabbit
renal cortex [128]. Portila and colleagues reported a 40 kD form
that is immunologically related to the pancreatic group I PLA2;
its activity is increased when rabbit renal proximal tubules are
exposed to anoxia [129].
In the heart, ischemia has a significant effect on a Ca2t
independent form of PLA2, which is selective for plasmalogens
[130]. The kidney also contains large amounts of plasmalogens.
When 14C-ethanolamine is infused into rats, there is greater
incorporation of radioactivity into the plasmalogen fraction
than into phosphatidylethanolamine. This preferential incorpo-
ration is greater in the kidney than in the heart or liver [131]. As
yet the literature contains no report of a renal PLA2 that has a
preference for plasmalogens as substrates.
While elevated cytosolic Ca2 concentration might be impor-
tant for activating the PLA2 enzymes in vivo with ischemia, the
preservation of increased activity in vitro under conditions of
our assay, in which Ca2 is fixed, suggests a stable modification
of the enzymes. Thus ischemia and reperfusion may produce a
covalent modification of the enzyme such that PLA2 activation
prevails even if [Ca2] levels return to baseline values in vivo
after ischemia. This persistent PLA2 activation may contribute
to the accumulation of arachidonic acid and metabolic products
of arachidonic acid in tissues after reperfusion [132].
Protein kinase C (PKC) may regulate PLA2 via phosphory-
lation [126]. Evidence suggests that PKC is activated during
ischemia [133]; phosphorylation of PLA2 might enhance its
activity. In the mesangial cell, PKC activation with phorbol
esters increases the Ca2 sensitivity of PLA, activity [126].
Recent studies suggest that a mitogen-activated protein kinase,
MAP kinase, is able to directly activate the 110 kD PLA2 [134].
Using glutamate stimulation of isolated rat brain cortical
neurons, we further found evidence for increased Ca2 sensi-
tivity of PLA2 in the cell culture model of ischemia. Excitatory
amino acid toxicity probably is of paramount importance in the
neuronal death that occurs with brain ischemia. Glutamate
stimulation of isolated neurons raises cytosolic Ca2 concen-
tration [135], PKC activity, and PLA2 activity in cytosolic
extracts of the cells [1101. The characteristics of this PLA2
activity approximate those of rat kidney and gerbil brain
cytosolic extracts. In the post-glutamate extracts, the Ca2
sensitivity of the small-molecular-weight form of PLA2 is in-
creased [110].
In addition to the possible mediation of Ca2 and PKC-
related ischemic cellular injury, PLA2 is likely an important
mediator of the injury that occurs in response to ROS in the
presence of increased amounts of Ca2. As I previously stated,
in isolated rat kidney mitochondria, the damage to the electron
transport chain, F1-ATPase, and adenine nucleotide translo-
case, observed when mitochondria are exposed to Ca2 and
reactive oxygen species, was substantially reduced by PLA2
inhibitors [48]. The alkaline pH optimum of the mitochondrial
form of the enzyme suggests that PLA2 activity is increased in
the alkaline environment of the mitochondrial matrix.
In summary, multiple forms of PLA2 are present in the
cytosolic and membrane (mitochondrial and microsomal) com-
partments of kidney and brain cells. The Ca2 concentration
sensitivities of cytosolic and membrane-bound PLA2 activities
indicate that the enzymes likely are regulated by Ca2 in vivo.
After ischemia and reperfusion in the kidney and brain, cyto-
solic, mitochondrial, and microsomal PLA2 enzymatic activi-
ties were increased. Although changes in [Ca2] might play a
permissive role in these stable modifications of enzymatic
activity, the changes in PLA2 activity probably are not ex-
plained by changes in [Ca2] alone and suggest that other
regulatory influences contribute significantly to PLA2 activation
and mediation of cellular injury after an ischemic insult.
Amino acids. Using renal tubules and renal epithelial cells in
culture, Weinberg and colleagues found that certain amino
acids can protect against injury associated with increases in
cytosolic free [Ca2], ROS, ATP depletion, and sodium-potas-
sium ATPase inhibition [136—138]; low millimolar concentra-
tions are necessary and glycine is most effective. The mecha-
nism of this protection is not known. Depletion of amino acids
such as glycine, which permeate cell membranes, might be
relevant clinically, especially in the transplanted kidney, which
can become depleted of glycine during storage [139].
Proteases. Renal brush-border membranes are rich in pro-
teases [140]. The involvement of these proteases, which include
meprin, endopeptidase 24.11, and exopeptidases, and the ion-
ized Ca2-dependent neutral cysteine proteinases, calpains
[141], in ischemic injury is not well understood.
Synergy. A complicating feature that frustrates biologists
trying to understand any biologic system is its inherent com-
plexity. Such is also the case with the study of cell injury and
cell death. It is clear that many of the factors we have discussed
do not work in isolation. They interact in complicated, poorly
understood ways. These interactions, together with the non-
specificity of interventions introduced to inhibit a particular
injurious influence, and the difficulty in defining the "point of no
return," all conspire to make it difficult to define the most
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important factors determining cell injury and death. The pessi-
mist concludes from this complexity that many factors are
important and the prevention of cell death, which will depend
on interference with multiple mechanisms, will not be feasible
at a clinical level. The optimist, like me, argues that one or two
of these factors are most important and that even when synergy
occurs, one or two factors will predominate. Hence therapeutic
intervention directed at these one or two factors will be
successful in preventing cell death.
One example of synergy that I already mentioned is the
detrimental effects on mitochondrial function that arise due to
interactions of Ca2 and phospholipase A2 and ROS [48].
Increased mitochondrial Ca2 and ROS can act synergistically
to confer a degree of toxicity that is far greater than that
expected simply from the additive toxicities of the two agents.
For example, we evaluated in vitro the damage produced to rat
renal cortical mitochondria after exposure to Ca2 alone, ROS
generated by hypoxanthine, xanthine oxidase and iron, or the
combination of Ca2 and ROS [48]. Mitochondrial electron
transport chain integrity, ATP synthetase (F1F0ATPase), and
adenine nucleotide translocase were evaluated. Mitochondria
exposed to ROS alone sustained an increase in substrate-
supported (state 4) respiration due to increased mitochondrial
membrane permeability, decreased ADP-stimulated (state 3)
respiration, and a 50% reduction in the respiratory control ratio
(state 3/state 4); F1F0ATPase was inhibited, but neither the
electron transport chain nor the ATP-ADP translocase was
damaged, In contrast, after exposure of mitochondria to small
amounts of Ca2 (30 nmol/mg mitochondrial protein), which by
itself did not change mitochondrial function, the addition of
ROS caused a greater increase in mitochondrial membrane
permeability, a major functional defect in the electron transport
chain, a marked decrease in F1F0ATPase and adenine nude-
otide translocase activity, and a complete uncoupling of oxida-
tive phosphorylation. The mechanism of this Ca2 potentiation
of ROS damage is, at least in part, via activation of phospho-
lipase A2. Dibucaine, a phospholipase A2 inhibitor, partially
protected the electron transport chain, F1F0ATPase, and ade-
nine nucleotide translocase from damage.
Apoptosis: Does it play a role in ischemic cell injury?
Until recently, the study of cell death received much less
attention than the study of cell proliferation and differentiation.
In general, cell death has been considered less interesting for
study because it has been seen as a degenerative process
characterized by necrosis. It is now recognized, however, that
certain types of cell death are finely controlled by active
processes. For example, during metamorphosis and develop-
ment, "programmed cell death" represents an important cellu-
lar response to physiologic stimuli that allow for the proper
formation of the organism. "Cell death" genes have been
identified in the nematode Caenorhabditis elegans [142]. Tes-
tosterone withdrawal results in involution of the prostate by a
process involving programmed cell death [1431. Abnormalities
in the control mechanisms for programmed cell death might
explain certain neurodegenerative diseases [144].
Most of the attention devoted to ischemic cell death has
focused on necrosis. The pathologic features of necrosis are
very different from those of programmed cell death. The latter
has been called "apoptosis," a term coined by Kerr et al, who
attribute the derivation of the term to Professor James Cormack
of the University of Aberdeen [145]. "Apoptosis" is a Greek
term that means "dropping off" or "falling off," as say, petals
from a flower or leaves from a tree. Pathologically, apoptosis is
characterized by chromatin condensation at the periphery of
the nucleus, condensation of the cytosol, diappearance of
microvilli, breakdown of epithelial desmosomal attachments,
and cell surface protuberance, followed by disruption of the
nucleus, and finally the blebbing off of cell surface protuber-
ances around condensed cytosol and perhaps some nuclear
fragments, thus generating spherical or ovoid "apoptotic bod-
ies" [146]. Macrophages or epithelial cells can phagocytose
these short-lived apoptotic bodies, which can be seen by light
microscopy in tissue for only 12 to 18 hours. The biochemical
correlate of chromatin condensation is cleavage of double-
stranded DNA at the linker regions between nucleosomes,
resulting in fragments of approximately 185 bp [147]. Agarose
gel electrophoresis reveals a characteristic "ladder pattern."
By contrast, necrosis is characterized by random DNA break-
down with a diffuse pattern seen on gel electrophoresis. The
endonuclease responsible for this electrophoretic pattern typi-
cal of apoptosis has not been well characterized. A candidate
enzyme is an endonuclease that is activated by calcium in
thymocytes [148]. In fact, under certain conditions, elevations
in intracellular calcium concentrations can induce apoptosis
[149]. It is therefore possible that Ca2 is involved in the
activation of apoptosis under pathophysiologic conditions. Un-
der many conditions of cell injury, one cell might undergo cell
death while an adjacent cell proliferates to replace the damaged
cell. It is interesting that phorbol esters can change the effects
of Ca2 elevation from cell death to proliferation in thymocytes
[149]. Clearly, the apoptotic process is under fine control.
I propose that apoptosis plays an important role in ischemic
cell injury. An understanding of the role of apoptosis in isch-
emic cell injury likely would facilitate pharmacologic interven-
tion directed toward the active cellular processes that occur
during the post-ischemic period and during periods of chronic
ischemia such as during renal artery stenosis. The question then
becomes: Is there any evidence for apoptosis with ischemic
acute renal failure? Gob et a! studied renal atrophy that
accompanies experimental renal artery stenosis [150]. During
the first 2 to 8 days after the partially occluding clip was placed
around the renal artery, they found pathologic evidence for
both necrosis and apoptosis of renal epithelial cells. From 10 to
28 days after clip placement, when renal mass was markedly
reduced, cell death continued, but only apoptosis was ob-
served. After unilateral renal atrophy had occurred, removal of
the contralateral kidney resulted in marked enlargement of the
atrophic kidney; thus the atrophic process was reversible. An
understanding of the factors involved in the reversal of the
apoptotic process might allow us to prevent the ischemic tissue
atrophy in the first place. Schumer and colleagues examined
renal tissue at various times after 5, 30, or 45 minutes of
ischemia [151]. A small number of apoptotic bodies were found
24 and 48 hours after reperfusion following 5 minutes of
ischemia; there was no associated necrosis. In the kidneys
clamped for 30 or 45 minutes, apoptosis was found at 12, 24,
and 48 hours of reperfusion. A ladder pattern of DNA fragmen-
tation also was observed 24 hours after 30 minutes of ischemia.
With increasing periods of ischemia, evidence for necrosis
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Fig. 2. Apoptosis in patient with acute renal
failure. A represents an apoptotic nucleus, V
represents a vacuole, and M represents a
mitotic figure.
increased. Figure 2 demonstrates apoptosis in a renal biopsy
specimen of a patient with acute renal failure.
Ischemia and reperfusion are accompanied by the induction
of various genes, including the gene encoding sulfated glyco-
protein-2 (SGP-2) [1521, also called clusterin and TRPM-2, a
gene that has been implicated in apoptosis in the prostate [143].
We have found that other genes, Egr-l and c-for, whose
expression is induced under many situations in which cells are
stimulated to proliferate, are also induced with ischemia and
reperfusion, and that protein levels of Egr-l increase to very
high levels in thick ascending limb nuclei [153, 154] (Fig. 3). The
control mechanisms responsible for the decision of a cell to die
via an apoptotic process, or to proliferate to replace adjacent
cells that have died will, I hope, become better understood as
cellular signaling and genetic mechanisms for
cell death" are better defined.
Apoptosis has been documented to be particularly prevalent
in post-transplant acute tubular necrosis [155]. Whether this
finding reflects fundamental differences in the pathophysiology
of ischemic acute renal failure between a native kidney and a
transplanted organ is not clear [1551. Joel Weinberg and I
reviewed the pathophysiologic factors implicated in ischemic
acute renal failure in the transplanted kidney [32].
Summary
The pathophysiology of ischemic acute renal failure is com-
plex. The morhidity and mortality associated with the clinical
problem remain unacceptably high; therefore it is imperative
that we continue a diligent search for a better understanding of
the mechanisms responsible for ischemic cell death. Such
knowledge might lead to therapeutic interventions directed at
the most important pathophysiologie factors responsible for the
tubular cell's demise and could have applications to other
organs frequently ravaged by the consequences of ischemia—
the heart and brain. At the same time, we must continue to
explore basic mechanisms responsible for renal repair, as the
kidney has the potential to completely recover, a property not
shared by heart or brain. By understanding the injury and repair
mechanisms 1191, t hope we wilt be able to prevent the tissue
damage and, when this is unsuccessful, hasten the repair
process or initiate it in kidneys where it otherwise would not
occur.
Questions and answers
DR. NIcoLAos E. MAD lAS (Chief, Divis ion of Nephrology,
New England Medical Center, Boston, Massachusetts): I was
interested in your finding that acidosis might protect renal
tubular cells from anoxic injury. You proposed as a possible
explanation an inhibitory effect on phospholipase A2 activity.
Dr. Hilden, who is in the audience, has shown in preliminary
studies induction of heat-shock proteins in the kidney by
isehemia and acidosis. I wonder whether such induction could
be another mechanism for the protective effect of acidosis. May
I ask that you and Dr. Hilden comment on this issue?
DR. BONVENTRE: The heat-shock response is remarkably
conserved during evolution. Cells exposed to various noxious
and potentially lethal stimuli, such as heavy metals, viruses,
calcium ionophores, and heat, respond by increasing the syn-
thesis of a group of proteins (the heat-shock or stress proteins),
while decreasing the synthesis of most other proteins [156, 157].
We reported that the mRNA levels of a member of the HSP 70
gene family are increased soon after an isehemic insult to the
kidney [1581. The mRNA levels are maximal at 3 hours after the
renal artery has been clamped for 40 minutes. These data are
shown in Figure 4, which presents a Northern blot analysis
demonstrating mRNA levels of HSP 70 and comparing them to
mRNA levels of Egr-l (also known as Zif-268, Krox-24,
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Fig. 3. Cryosiat sections of outer medulla of
ischemic rat kidney after one hour of
reperfusion, stained with an antibody, to the
Egr-J protein. (A) Outer strip of outer medulla
showing positive staining of nuclei of thick
ascending limhs (arrows) and collecting duets.
The nuclei of straight proximal tubules (PT) in
the outer stripe are not stained. (B) Inner
stripe of outer medulla showing heavy nuclear
staining of thick ascending limbs (TAL) and
collecting ducts (CD). In addition, the nuclei
of some thin limbs and capillaries appear to
be fluorescent. Bar = 50/sm (from reference
[154]).
NCR-A, and TJS-8) [159], an early growth response gene that
is also markedly and transiently induced with ischemia.
We were most successful in demonstrating a protective effect
of this heat—shock response using a model for ischemic injury in
the brain [1601, in which amino acid excitotoxicity is believed to
play a critical pathophysiologic role. We established cultures of
cortical neurons and exposed these neurons to glutamate. The
glutamate-induced excitotoxicity was inhibited by preheating
cells to 42.2°C for 20 minutes. This protection was afforded to
cells subsequently exposed to glutamate 3 or 24 hours after they
were heated. Protection required new protein synthesis. I
would be interested in knowing whether Dr. Hilden has any
further comments.
DR. SHIRLEY A. HILDEN (Division of Nephrology, New
England Medical Center): Dr. Madias, Conrado Johns, nnd I
found that renal function is protected in rats that were treated
with heat—shock 2 days before the isehemic insult, at least as
demonstrated by a normal creatinine. I'm interested in cone-
lating some of the changes that occur in ischemic kidneys and
the synthesis and aggregation of heat-shock proteins, especially
in terms of your discussion about the adenine nucleotide
changes in isehemia. My results could he explained by an
aggregation of heat-shock proteins with proteins that are in the
process of being synthesized and require ATP for proper
processing. When ATP is reduced by isehemia, the ensuing
aggregation of heat-shock proteins might reflect a disturbance
of normal protein synthesis and processing.
Da. MAmAs: Wasn't acidosis by itself also an inducer of the
heat—shock response?
Da. HtLr.wN: I'm interested in characterizing different heat-.
shock proteins in different experimental situations, not just
ischemia. The situations we're looking at include acidosis. The
protein heat—shock 60 (HSP 60), for example, increased as a
function of acidosis. We also saw that aeidotic animals that
were subsequently treated with ischemia lost this acidosis-
induced HSP 60 induction, I'm not sure how that result relates
to your observations about acidosis being protective.
Dn. BONYENTRE: My working hypothesis is that the aeidosis-
induced protection against anoxic injury that we observed in
kidney and liver is related to an inhibition of phopholipase A2
activity due to the pH dependency of the cytosolie, mitochon-
drial, and microsomal PLA2s in the cell. Dr. Hilden's results
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Figure 4. Northern blot analysis of Egr-1 and HSP-70 mRNA accumulation in rat kidney after 40 mm of unilateral ischemia and varying periods
of reperfus ion. Total RNA was prepared from both postisehemic kidney (+) and contralateral norijschemic (—) kidneys removed at varying times
after reperfusion. (C)—RNA obtained from a control kidney obtained from an animal not subjected to ischemia. Blots were hybridized with Egr-l
or HSP-70 eDNA probes. The blots also were hybridized with a cDNA probe encoding a "housekeeping" protein (P31). Positions of ISS and 285
mRNA are marked. (From Ftefs. 154 and 158.)
indicating that acidosis may induce expression of one or more
members of the HSP 60 family are possibly relevant to the
acidosis-induced protection. The effect of acidosis on expres-
sion of DNA binding of a pre-existing heat-shock factor to the
HSP 70 heat-shock element was examined by Benjamin et al
[161]. Whole-cell extracts were examined in gel shift reactions
using an oligonucleotide containing the heat-shock element
consensus region. Energy depletion associated with ATP de-
pletion stimulated heat-shock-factor binding, hut acidosis
alone, without ATP depletion, did not have any effect. 1 would
like to add something that I neglected to mention previously.
Together with Drs. Barbara Polla and Yves Donati, who are at
the Hôpital Cantonal Universitaire in Geneva, Switzerland, we
evaluated whether the heat-shock response protected against
acute ischemic injury in rats (unpublished data). We induced
the response by raising the temperature of anesthetized rats to
42t for 20 minutes. This change resulted in a large increase in
HSP-70 mRNA levels. Four to six hours later we produced
bilateral renal ischeniia for 40 minutes and followed renal
function by monitoring BUN and creatinine for 7 days post
isehemia. We found no protection associated with prior gener-
ation of the heat—shock response. Perhaps we would have found
protection had we wailed a longer period of time between the
generation of the heat-shock response and the ischemia. Emami
et al reported that accumulation of HSP—72 protein in kidney is
maximal within 4 to 6 hours after heat stress and persists for 10
days [1621.
DR. MADrAs: Other investigators have shown enhanced
post-isehemic cardiac ventricular recovery 24 hours after hy-
perthermic treatment and induction of the 71 kD heat-shock
proteins 1163].
DR. JOHN T. HARRINOTON (Chief of Medicine, Newton-
Wellesley Hospital, Newton, Massachusetts): What do the
so-called heat-shock proteins do before they get shocked by
heat? Do they have a role in normal cellular metabolism?
DR. BONVENTRE: Some constitutive members of the heat-
shock family of proteins function in normal cell physiology. For
example, the heat-shock cognate HSC 70 aggregates with
denatured proteins. It has been proposed that this heat-shock
protein normally binds to the heat-shock factor, which is a
protein that potentiates the transcription of genes containing
heat-shock elements. Under normal circumstances, the heat-
shock factor is inactivated by its interaction with FISC 70.
When the cell is shocked, the amount of denatured proteins that
compete with heat-shock factor for binding to HSC 70 in-
creases; heat-shock factor is released, DNA binding of the
factor increases, and heat-shock protein synthesis increases
[164]. Under normal conditions, HSC 70 probably acts as a
molecular chaperone, delivering nascent unfolded polypeptides
made in the cytosol to the rough endoplasmic reticulum and
a
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mitochondria [165, 166]. Another HSP 70 family member, GRP
78, also called BIP, is localized to the lumen of the endoplasmic
reticulum and associates with nascent glycoproteins and secre-
tory proteins; BiP presumably prevents abnormal folding and
aggregation. Another abundant cellular heat-shock family is the
HSP 90 family. HSP 90 associates with steroid receptors,
chaperoning the receptor until steroid hormone is available to
bind to it [10, 167].
DR. HARRINGTON: It's well known that medullary blood flow
is a relatively small percentage of overall renal blood flow.
Why, then, does a reduction in outer medullary blood flow have
such a profound effect on overall glomerular filtration rate?
DR. BONVENTRE: Although blood flow to the medulla is much
less than that of the cortex, the relative changes in blood flow to
this area of the kidney post ischemia are quite large. As I
indicated, the blood flow decreased to 16% of normal in the
outer medulla 60 minutes after ischemia, whereas cortical blood
flow was 60% of pre-ischemic levels, and inner medullary flow
was 125% of pre-ischemic levels [7]. This decreased outer
medullary blood flow has been attributed to the vascular
congestion secondary to the outwardly directed swelling of
proximal tubular cells [5]. This decreased blood flow, together
with the countercurrent exchange of oxygen along the corti-
comedullary axis, with graded reduction in tissue oxygen
tension with increasing distance from the corticomedullary
boundary, is likely to result in severe compromise of oxygen
delivery to cells of the outer medulla, which depend on oxida-
tive metabolism for their viability [168]. Since most human
nephrons have loops of Henle that traverse the outer medulla,
nephron damage to the tubular epithelium in this area is likely to
have significant consequences in the form of tubular obstruction
and backleak in a large number of nephrons.
DR. ANDREW KING (Division of Nephrology, New England
Medical Center): Most investigators have observed, both in
humans and in animal models, a substantial reduction in both
renal blood flow and GFR, with a disproportionate fall in GFR.
In addition, the autoregulatory ability of the renal vasculature is
impaired. Early in your presentation, you said that glomerular
endothelial cells were swollen following ischemia. What role do
you think the endothelial cells play? Are they potentially factors
that could affect renal vascular tone, tubular damage, and
tubular recovery? In particular I'm interested in your thoughts
about endothelin, as several investigators have shown an in-
crease in renal endothelin production after acute ischemia.
Da. BONVENTRE: The endothelial cells are involved in a
central way in the regulation of vascular tone, They produce
and release potent vasodilators, including prostacycin (PGI2)
and endothelium-derived relaxation factor (EDRF) identified as
nitric oxide [169], They also produce potent vasoconstrictive
agents including platelet activating factor, platelet-derived
growth factor, and endothelin-l [170].
Endothelin might play an important role in post-ischemic
vasoconstriction. Administration of anti-endothelin antibodies
into a branch artery of the main renal artery resulted in
decreased renal vasoconstriction post ischemia [171].
Other mediators derived from the endotheliurn also might
contribute to the tubular damage. Endothelial cells can produce
interleukins or may express leukocyte adhesion molecules on
their surface, which might be important for an inflammatory
response and probably increases neutrophil infiltration and
exacerbates the injury. Finally, factors produced by the endo-
thelium could be important for tissue repair.
Da. MADIAS: As you and Dr. King noted, several experimen-
tal studies have shown impaired autoregulation of renal blood
flow following ischemia. Indeed, some observations in humans
appear to support the clinical relevance of this loss of autoreg-
ulation [172]. Could you comment on the significance of recur-
rent episodes of hypotension, including those related to dialy-
sis, in recurrent ischemic injury to the kidney?
DR. BONVENTRE: The post-ischemic kidney has abnormal
autoregulation of renal blood flow. This alteration has been
demonstrated in dogs [173] and rats [174]. Thus a subsequent
reduction in arterial pressure might be expected to produce a
greater decrease in renal blood flow in the post-ischemic kidney
than it would in normal kidneys. As you suggest, therefore, the
transient hypotension that frequently accompanies hemodialy-
sis in the patient with acute renal failure might result in
additional tissue ischemia, further delaying the recovery of the
patient. This remains controversial, however, because some
investigators have found in experimental animals that a prior
episode of ischemia partially protects the kidney against a
second ischemic episode [175]. This protection might be due to
less susceptibility of regenerating tubular epithelium to isch-
emia. If recovery from acute renal failure recapitulates aspects
of early renal development, the regenerating epithelial cell
might be similar to the tubules of young animals, which are
known to be more resistant to ischemic injury [176]. Another
possible reason for decreased cellular susceptibility to a second
ischemic insult is the presence of protective factors in the cell
that are induced as a result of the first ischemic episode. Heat-
shock proteins are candidates for this type of protective func-
tion, as we previously discussed. Another explanation for
protection of the post-ischemic kidney against subsequent
ischemia is that the increased sodium and osmotic load to each
of the remaining functional nephrons is protective. Additional
possible reasons for resistance to a second insult include:
inability of the damaged kidney to concentrate a toxic sub-
stance, decreased responsiveness of the damaged kidney to
vasoconstrictive substances, and increased levels of reactive
oxygen species scavengers in renal cells [177, 1781.
DR. AJAY K. SINGH (Division of Nephrology, New England
Medical Center): In your excellent presentation, you talked
about the role of cell necrosis and about programmed cell death
in ischemic injury. You hinted that the apoptosis component of
the injury might be accelerated in the ischemic kidney. Is there
evidence for this? In particular, are regulatory genes that might
be involved in apoptosis up-regulated?
DR. BONVENTRE: One gene that has been implicated in
apoptosis is sulfated glycoprotein-2 (SGP-2), also called testos-
terone-repressed prostate message-2 (TRPM-2) and clusterin.
This gene initially was implicated in apoptosis because it is
up-regulated when the prostatic cell undergoes "programmed
cell death" after testosterone is removed, and in the interdigital
region during limb morphogenesis [143]. Expression of this
gene, as measured by accumulation of mRNA, is up-regulated
in ischemic injury with a time course that is more prolonged
than that observed with Egr-l or heat-shock protein genes [179,
180].
DR. SINGH: One could speculate, somewhat simplistically,
that cell necrosis results in the release of nuclear factors that
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somehow up-regulate cis-acting gene-regulating segments im-
portant in apoptosis. For this hypothesis to be accurate, one
would expect cell necrosis to precede apoptosis. Do you know
of any pathologic studies in ischemic renal injury that examine
the chronologic relationship between cell necrosis and apopto-
sis?
DR. BONVENTRE: Drs. Gobd, Axelsen, and Searle, in a
pathologic study of chronic renal ischemia, have reported the
chronologic relationships between cell necrosis and apoptosis
[150]. Ischemia was induced by unilateral renal artery stenosis.
During days 2 through 8 after a partially occluding clip was
placed on the artery, they found pathologic signs of both
necrosis and apoptosis accounting for cell death. From days 10
through 28, by contrast, cell death was due to apoptosis alone.
Schummer et a! induced ischemia by occlusion of the renal
artery for 5, 30, or 45 minutes [151]. A few apoptotic cells were
present 12, 24, or 48 hours after a short S-minute period of
ischemia. As the period of ischemia was prolonged to 30 or 45
minutes, the number of apoptotic cells markedly increased at 24
and 48 hours after the ischemia. When DNA was isolated 24
hours after kidneys were clamped for 30 minutes, there was a
series of 180—200 base pair fragments, which formed a ladder
pattern typical of apoptosis.
Da. BRIAN J. G. PEREIRA (Division of Nephrology, New
England Medical Center): At the International Symposium on
the Diagnosis, Treatment, and Prevention of Acute Renal
Failure at Edmonton, the term "acute tubular non-replace-
ment" was introduced to explain the total absence of cells along
the tubular epithelium in patients with acute renal failure. What
is your opinion about this term?
My second question relates to the patient you described. He
clearly had a first insult that led to acute renal failure, recov-
ered, and had a second insult. Could you expand on the relative
increase in susceptibility in humans and laboratory animals
recovering from acute renal failure?
DR. BONVENTRE: The term "acute tubular non—replacement"
seems awkward. It is not clear what triggers replacement of the
epithelial cells. A large variation exists in the time from insult to
recovery of function and normalization of histology. The period
of time that elapses prior to recovery cannot be predicted by the
initial character of the insult. I believe that recovery of the
epithelium recapitulates developmental paradigms, and a better
understanding of the latter will, I hope, lead to a better
understanding of recovery from acute renal failure.
I believe that recovery from ischemic acute renal failure is
likely regulated by a number of genetic events, some of which
involve the up-regulation of genes important for dedifferentia-
tion and proliferation, and others involving the down-regulation
of genes that are important for differentiation and growth arrest.
Some of the genes involved might be kidney-specific, others
not. We recently identified a new transcription factor, which is
primarily expressed in the kidney and whose mRNA decreases
in content in the kidney after ischemia or following folic acid
administration [179]. Folic acid induces acute renal failure with
marked tubular cell injury. This cDNA encodes a predicted
protein with 13 zinc fingers, which is a motif common to
DNA-binding proteins. We have called this new gene Kid-i.
Kid-i is also developmentally regulated. Its expression in-
creases with increasing time of postnatal development. There-
fore its expression is decreased when renal cell proliferation
occurs. When a chimeric construct of the non-zinc-finger region
of Kid-i and the DNA binding region of GAL4 is transfected
into kidney cells along with chioramphenicol acetyl transferase
reporter plasmids containing GAL4 binding sites, transcrip-
tional activity is markedly suppressed; this suggests that Kid-i
is a transcriptional repressor.
With regard to your second question, I have discussed the
controversy surrounding the susceptibility, or lack thereof, of
the kidney to a second ischemic insult. It is not straightforward
to apply these data in animals to our patient. In this patient the
second insult involved sepsis in addition to hypotension. Had
the hypotension occurred in the absence of sepsis, the second
bout of acute renal failure might not have occurred. There is a
strong association between sepsis and acute renal failure,
although the reasons for this association are not clearly estab-
lished. Worldwide, sepsis is an important predisposing factor to
the development of acute renal failure both in adult and
pediatric populations. Sepsis also has an important influence on
outcome in patients with acute renal failure [181]. The patho-
physiologic mechanisms responsible for the frequent associa-
tion of acute renal failure with sepsis are not well understood.
DR. MADIAS: You made several parallelisms between the
heart and the kidney and also touched on the role of calcium
blockers in ischemic cell injury. Would you address the issue of
angiotensin-converting enzyme (ACE) inhibition? Several stud-
ies have shown that these agents have a protective effect against
the myocardial damage occurring during the reperfusion phase
following acute myocardial ischemia [182—184], but I am not
aware of such an effect in the kidney.
DR. BONVENTRE: The effects of angiotensin-converting-en-
zyme inhibition on renal function are quite complex and are
very dependent on volume status of the subject and whether
renal artery stenosis is present. The latter is always an impor-
tant consideration since many of our patients with acute isch-
emic renal failure have vascular disease and may have renal
artery disease, which has not necessarily been recognized.
Since renin levels are reported to be high in some studies of
acute renal failure [185], it is possible that angiotensin II
contributes to intrarenal vasoconstriction. It is also known that
angiotensin II can reduce the glomerular ultrafiltration coeffi-
cient, K1 [186], and this change might contribute to the reduced
GFR. Many reports conflict regarding a potential role for the
renin-angiotensin system in the pathophysiology of acute isch-
emic renal failure [187]. These differences may relate to the
various models of renal failure used and the inability to distin-
guish whether protective effects of volume expansion are due to
decreased activity of renin-angiotensin system or to indepen-
dent physiologic effects on other effector mechanisms.
DR. KING: Given the array of cellular events that you
outlined in your talk, could you give us any indication whether
there is a prescribed pretreatment for patients who are going to
undergo an ischemic event? Do you have any recommenda-
tions?
DR. BONVENTRE: Since it is clear that volume depletion
predisposes to acute ischemic renal failure, any patient who is
in danger of undergoing an ischemic insult to the kidney should
be well hydrated. In the case of mechanical interruption of
blood flow to the kidney, for example, in the repair of an
abdominal aortic aneurysm, pre-infusion of mannitol into the
kidney may be protective. Pretreatment with mannitol affords
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protection in animal models of acute renal failure in which the
renal artery is temporarily occluded [32], Presumably this
protection is based on mannitol's ability to prevent cell swell-
ing, thus decreasing outer medullary vascular congestion; in
addition, mannitol prevents tubular obstruction because of its
diuretic action. Also, mannitol is a hydroxyl radical scavenger.
Although mannitol has not been shown to be protective in
human acute ischemic renal failure, it is frequently adminis-
tered prior to renal artery occlusion.
Cell-impermeant solutes have proved effective in the preser-
vation of the kidney ex vivo for transplantation [139]. A number
of other agents have been administered to the kidney ex vivo to
decrease the incidence of delayed graft function secondary to
ischemic injury. Adenosine has been added to the preservation
solution to enhance the purine nucleotide precursor pool.
Glutathione has been added to counteract the reduction in
tissue glutathione levels seen with ischemia [188, 189]. Calcium-
channel blockers have been protective in ex-vivo tissue storage
[190, 191], likely because they inhibit vasoconstriction, as
observed in animal models of norepinephrine-induced acute
renal failure [32]. At present, I do not believe that one can
recommend with conviction that any of these agents be admin-
istered in vivo to assure protection against ischemic injury. The
possible exception is mannitol although, as I stated, the data are
weak and clinical trials are needed to test its effectiveness. If
this agent is administered, one must be careful to avoid volume
depletion; acute renal failure has been associated with mannitol
therapy [192]. I believe these cases were likely due to volume
depletion, with resultant renal vasoconstriction and increased
susceptibility of the kidney to reduced blood pressure or other
insults that compromise renal perfusion.
DR. MADIAS: Is it known whether the levels of antioxidant
enzymes change with ischemia?
DR. BONVENTRE: It has been reported that cell glutathione
levels fall with ischemia [188, 189]. Glutathione detoxifies
hydrogen peroxide via glutathione peroxidase. In contrast,
Yoshioka and colleagues have demonstrated that ischemia and
reperfusion augments glomerular glutathione, superoxide dis-
mutase, and catalase 6 days after the ischemic insult [1781.
Mechanisms responsible for the induction of synthesis of an-
tioxidant enzymes are not understood. This finding in the
kidney is similar to the increased production of antioxidant
enzymes in the lung after exposure to high oxygen tension or
endotoxin [193, 194].
DR. MICHAEL LINSHAW (Chief, Division of Pediatric Neph-
rology, The Floating Hospital for Infants and Children, New
England Medical Center): Is the cause for salt wasting that
occurs during the recovery phase a change in the polarity of the
cell and a redistribution of the ATPase?
DR. BONVENTRE: Acute renal failure is associated with an
impaired ability to reabsorb sodium and water, as reflected by
increases in fractional excretion of sodium and decreased
concentrating ability. Even with mild ischemic insults in exper-
imental animals, there is loss of apical and basolateral cell
polarity with apical membrane localization of the Na—K
ATPase, an enzyme that normally is confined to the basolateral
membrane [24, 195]. It is possible that during the recovery
phase the regenerating epithelium contains cells that are not
fully differentiated and polarized thus contributing to sodium
wasting.
DR. KLEMENS MYER (Division of Nephrology, New England
Medical Center): Do I infer correctly that the observation of
apoptosis is still qualitative?
DR. BONVENTRE: Correct. There's been no detailed quanti-
tative morphometric analysis of the extent of apoptosis present
in different clinical conditions of acute renal failure.
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